TriangleNCT01466881 · OUTCOME
Overall Survival (OS)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- Months
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- Up to 2 years after registration
What was measured
Measure from date of registration to date of death due to any cause. Patients last known to be alive are censored at date of last contact.
Analysis population: Only eligible patients were included in the analysis.
Groups in this outcome
MLN8237
Patients receive MLN8237 (alisertib) PO BID on days 1-7. Treatment repeats every 21 days for 17 courses in the absence of disease progression or unacceptable toxicity
| Group | Source count |
|---|---|
| MLN8237 | 37 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| MLN8237 | 8 | Not reported | 4.5 | 9.5 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 4.5
- upper Limit
- 9.5
- value
- 8
- denoms
- counts
- group Id
- OG000
- value
- 37
- units
- Participants
- description
- Measure from date of registration to date of death due to any cause. Patients last known to be alive are censored at date of last contact.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Patients receive MLN8237 (alisertib) PO BID on days 1-7. Treatment repeats every 21 days for 17 courses in the absence of disease progression or unacceptable toxicity
- id
- OG000
- title
- MLN8237
- param Type
- MEDIAN
- population Description
- Only eligible patients were included in the analysis.
- reporting Status
- POSTED
- time Frame
- Up to 2 years after registration
- title
- Overall Survival (OS)
- type
- SECONDARY
- unit Of Measure
- Months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice